Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cuitang Granules for Influenza (Phase III)
CTR20181817Phase 3Active
- Sponsor
- Gansu Qizheng Tibetan Medicine
- Start
- Jan 2019
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Cuitang granules in influenza, sponsored by Gansu Qizheng Tibetan Medicine. Started Jan 2019; status: active.
02
Drugs
Cuitang granules
03
Conditions
influenza
Beyond the preview
Go deeper on CTR20181817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20181817.